CTRI/2023/05/053239尚未招募4 期
CEFRTRIAXONE, SULBACTUM, DISODIUM EDTA & COLISTIN VERSUS MEROPENEM & COLISTIN FOR THE TREATMENT OF MULTIDRUG RESISTANT- VENTILATOR ASSOCIATED PNEUMONIA : A RANDOMIZED CONTROL STUDY
SGRD Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age > 18 years
- •2) Primary diagnosis of VAP based on the the presence of ventilator associated events (VAE) which are consisted of [Ventilator associated condition (VAC)- worsened oxygenation + Increase in positive expiratory pressure by 3 cm or increase in FiO2 by 2% , Infection related ventilator associated condition (IVAC)- fever >38C or hypothermia < 36C or WBC < 4000/ > 12000 and antibiotics for least 4 days and positive microbiological result.]
- •3) Positive culture of MDR ( Acinetobacter baumanii, Klebsiella pneumoniae)
- •4) Patients who will be (meropenem and AAE resistant).
- •5) Hospitalization for more than 5 days.
- •6) Subjects with clinically significant cardiovascular, renal, hepatic, gastrointestinal conditions, neurological, psychiatric, respiratory, other severely immunocompromised, hematological or malignant disease, history of uncontrolled diabetes mellitus, HIV and hepatitis-B and other condition which may interfere with the assessment will be carefully assessed and any significant information will be recorded and reported.
排除标准
- •1)Patients who will receive treatment for less than 72hrs.
- •2)Subjects with history of resistance to any of the investigational drugs, history of hypersensitivity, allergic response or any contraindications to penicillin, cephalosporin or carbapenem groups of drugs, history of hearing loss
- •3)Participation in any clinical study during data collection period.
- •4)Pregnant or lactating mother
研究者
相似试验
进行中（未招募）
不适用
EOADJUVANT EPIRUBICIN-OXALIPLATIN-XELODA AND OXALIPLATIN-XELODA-RADIOTHERAPY IN LOCALLY ADVANCED, RESECTABLE, GASTRIC CANCER. A PHASE II COLLABORATIVE STUDY - NEOX-RT STUDYPATIENTS WITH OPERABLE GASTRIC ADENOCARCINOMAMedDRA version: 9.1Level: LLTClassification code 10061968Term: Gastric neoplasmEUCTR2008-002715-40-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO
招募中
2 期
Dexamethasone, ifosfamide, carboplatin, and etoposide in treating patients with refractory lymphoblastic lymphoma.ymphoblastic lymphomaJPRN-UMIN000016346Japan children's cancer group.24
进行中（未招募）
不适用
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone plus Rituximab (CHOP-R) and Cyclophosphamide, Pixantrone, Vincristine, Prednisone plus Rituximab (CPOP-R) in Elderly Patients with Diffuse Large-B-cell Lymphoma: A Phase II, Randomized, Multicenter, Comparative Trial'Diffuse Large-Bcell LymphomaMedDRA version: 14.1Level: PTClassification code 10012818Term: Diffuse large B-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-001100-40-ITCELL THERAPEUTICS INC. SEDE SECONDARIA280
进行中（未招募）
不适用
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone plus Rituximab (CHOP-R) andCyclophosphamide, Pixantrone, Vincristine, Prednisone plus Rituximab (CPOP-R) inPatients with Diffuse Large-B-cell Lymphoma: A Phase II, Randomized,Multicenter, Comparative TrialDiffuse large B-cell lymphoma.MedDRA version: 13.1Level: PTClassification code 10012818Term: Diffuse large B-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-001100-40-DECell Therapeutics Europe S.r.l.280
招募中
2 期
Fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in non-resectable pancreatic cancer patients.Pancreatic cancerJPRN-UMIN000005808Yokohama City University Graduate School of Medicine60